Press release
Staphylococcus aureus Bacteremia Treatment Market 2032: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Basilea Pharma, Armata Pharma, Destiny Pharma
Staphylococcus aureus Bacteremia Treatment Market
The Staphylococcus aureus Bacteremia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Staphylococcus aureus Bacteremia pipeline products will significantly revolutionize the Staphylococcus aureus Bacteremia market dynamics.
To Know in detail about the Staphylococcus aureus Bacteremia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Staphylococcus aureus Bacteremia Market Insights
https://www.delveinsight.com/sample-request/staphylococcus-aureus-bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key facts of the Staphylococcus aureus Bacteremia Market Report:
• The Staphylococcus aureus Bacteremia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In Novemvber 2023, Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a biotechnology firm specializing in pathogen-targeted bacteriophage therapies for antibiotic-resistant and challenging bacterial infections, announced a rapid increase in participant enrollment for the Phase 2a segment of the diSArm study evaluating AP-SA02 as a prospective therapy for Staphylococcus aureus bacteremia. Additionally, they highlighted progress in the Phase 2 Tailwind study assessing AP-PA02 in individuals with non-cystic fibrosis bronchiectasis (NCFB) and lung infections caused by Pseudomonas aeruginosa.
• As per National Nosocomial Infection Surveillance [NNIS], (2003), System data demonstrate a steady increase in the incidence of nosocomial infections caused by methicillin-resistant S. aureus (MRSA) among ICU patients over time. MRSA now accounts for >60% of S. aureus isolates in US hospital ICUs
• Spain reported an incidence of 14 SAB per 100,000 inhabitants from April 2002 to March 2003 through EARSS surveillance scheme among which 25% was estimated to be MRSA
• Key Staphylococcus aureus Bacteremia Companies: Basilea Pharmaceuticals, Armata Pharmaceuticals, Inc., Destiny Pharmaceuticals, and others
• Key Staphylococcus aureus Bacteremia Therapies: Ceftobiprole, AP-SA02, XF-73, and others
• The Staphylococcus aureus Bacteremia epidemiology based on gender analyzed that male gender is consistently associated with increased Staphylococcus aureus Bacteremia incidence with male-to-female ratios of ∼1.5. The basis for this increased risk is not understood
Staphylococcus aureus Bacteremia Overview
Staphylococcus aureus bacteremia, often referred to simply as S. aureus bacteremia, is a serious bloodstream infection caused by the bacterium Staphylococcus aureus. S. aureus is a common type of bacteria that normally resides on the skin and in the nasal passages of healthy individuals without causing any harm. However, when it enters the bloodstream, either through a breach in the skin or from another site of infection, it can lead to bacteremia.
Get a Free sample for the Staphylococcus aureus Bacteremia Market Report:
https://www.delveinsight.com/report-store/staphylococcus-aureus-bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Staphylococcus aureus Bacteremia Market
The dynamics of the Staphylococcus aureus Bacteremia market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.
Staphylococcus aureus Bacteremia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Staphylococcus aureus Bacteremia Epidemiology Segmentation:
The Staphylococcus aureus Bacteremia market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Staphylococcus aureus Bacteremia
• Prevalent Cases of Staphylococcus aureus Bacteremia by severity
• Gender-specific Prevalence of Staphylococcus aureus Bacteremia
• Diagnosed Cases of Episodic and Chronic Staphylococcus aureus Bacteremia
Download the report to understand which factors are driving Staphylococcus aureus Bacteremia epidemiology trends @ Staphylococcus aureus Bacteremia Epidemiological Insights
https://www.delveinsight.com/sample-request/staphylococcus-aureus-bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Staphylococcus aureus Bacteremia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Staphylococcus aureus Bacteremia market or expected to get launched during the study period. The analysis covers Staphylococcus aureus Bacteremia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Staphylococcus aureus Bacteremia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
To know more about Staphylococcus aureus Bacteremia treatment, visit @ Staphylococcus aureus Bacteremia Medications
https://www.delveinsight.com/sample-request/staphylococcus-aureus-bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Staphylococcus aureus Bacteremia Therapies and Key Companies
• Ceftobiprole: Basilea Pharmaceuticals
• AP-SA02: Armata Pharmaceuticals, Inc.
• XF-73: Destiny Pharmaceuticals
Scope of the Staphylococcus aureus Bacteremia Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Staphylococcus aureus Bacteremia Companies: Basilea Pharmaceuticals, Armata Pharmaceuticals, Inc., Destiny Pharmaceuticals, and others
• Key Staphylococcus aureus Bacteremia Therapies: Ceftobiprole, AP-SA02, XF-73, and others
• Staphylococcus aureus Bacteremia Therapeutic Assessment: Staphylococcus aureus Bacteremia current marketed and Staphylococcus aureus Bacteremia emerging therapies
• Staphylococcus aureus Bacteremia Market Dynamics: Staphylococcus aureus Bacteremia market drivers and Staphylococcus aureus Bacteremia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Staphylococcus aureus Bacteremia Unmet Needs, KOL's views, Analyst's views, Staphylococcus aureus Bacteremia Market Access and Reimbursement
Discover more about therapies set to grab major Staphylococcus aureus Bacteremia market share @ Staphylococcus aureus Bacteremia market forecast
https://www.delveinsight.com/sample-request/staphylococcus-aureus-bacteremia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1. Staphylococcus aureus Bacteremia Market Report Introduction
2. Executive Summary for Staphylococcus aureus Bacteremia
3. SWOT analysis of Staphylococcus aureus Bacteremia
4. Staphylococcus aureus Bacteremia Patient Share (%) Overview at a Glance
5. Staphylococcus aureus Bacteremia Market Overview at a Glance
6. Staphylococcus aureus Bacteremia Disease Background and Overview
7. Staphylococcus aureus Bacteremia Epidemiology and Patient Population
8. Country-Specific Patient Population of Staphylococcus aureus Bacteremia
9. Staphylococcus aureus Bacteremia Current Treatment and Medical Practices
10. Staphylococcus aureus Bacteremia Unmet Needs
11. Staphylococcus aureus Bacteremia Emerging Therapies
12. Staphylococcus aureus Bacteremia Market Outlook
13. Country-Wise Staphylococcus aureus Bacteremia Market Analysis (2019-2032)
14. Staphylococcus aureus Bacteremia Market Access and Reimbursement of Therapies
15. Staphylococcus aureus Bacteremia Market Drivers
16. Staphylococcus aureus Bacteremia Market Barriers
17. Staphylococcus aureus Bacteremia Appendix
18. Staphylococcus aureus Bacteremia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Trending Report:
• Exocrine Pancreatic Insufficiency Market: https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Hyperuricemia Market: https://www.delveinsight.com/report-store/hyperuricemia-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Thymic Carcinoma Market: https://www.delveinsight.com/report-store/thymus-cancer-market
• Arteriovenous Fistula Market: https://www.delveinsight.com/report-store/arteriovenous-fistula-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Non Alcoholic Fatty Liver Disease Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Carcinoid Tumor Market: https://www.delveinsight.com/report-store/carcinoid-tumor-market
• Fibrocystic Breast Condition Market: https://www.delveinsight.com/report-store/fibrocystic-breast-condition-market
• Hiatal Hernia Market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Anterior Cruciate Ligament Injuries Market: https://www.delveinsight.com/report-store/anterior-cruciate-ligament-injuries-market
• Pediatric Obesity Market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Vestibular Schwannoma Market: https://www.delveinsight.com/report-store/vestibular-schwannoma-market
• Chemotherapy Induced Febrile Neutropenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-febrile-neutropenia-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Critical Limb Ischemia Market: https://www.delveinsight.com/report-store/critical-limb-ischemia-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Onycholysis Market: https://www.delveinsight.com/report-store/onychomycosis-market
• Acute Coronary Syndrome Market: https://www.delveinsight.com/report-store/myocardial-infarction-market
• Pruritus Market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Pharmaceutical Consulting Companies: https://www.delveinsight.com/consulting
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Acute Pulmonary Embolism Market: https://www.delveinsight.com/report-store/acute-pulmonary-embolism-market
• Apraxia Market: https://www.delveinsight.com/report-store/apraxia-market
• Cellulitis Market: https://www.delveinsight.com/report-store/cellulitis-market
• Healthcare Consulting: https://www.delveinsight.com/consulting
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/asco-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Staphylococcus aureus Bacteremia Treatment Market 2032: FDA Approvals, Clinical trials, Therapies, Prevalence and Companies by DelveInsight | Basilea Pharma, Armata Pharma, Destiny Pharma here
News-ID: 3589196 • Views: …
More Releases from DelveInsight Business Research
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals.
Objective of the Case Study
The…
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics.
According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than…
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies.
Biopsy devices play a crucial role in disease diagnosis by…
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide.
DelveInsight's General Surgery Devices Market Report 2032 provides…
More Releases for Staphylococcus
Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025?
In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in…
Leading Growth Driver in the Methicillin-Resistant Staphylococcus Aureus (MRSA) …
What market dynamics are playing a key role in accelerating the growth of the methicillin-resistant staphylococcus aureus (mrsa) drugs market?
The growth of the methicillin-resistant Staphylococcus aureus drugs market is expected to be fuelled by the rise in Hospital Acquired Infections (HAIs). Patients acquire these infections while being treated at a healthcare center, usually 48 hours or more post admissions. The root causes behind HAIs include contaminated medical apparatus, lax hand…
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Maufacturing Cos …
Qyresearchreports include new market research report "Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Status and Forecast 2022" to its huge collection of research reports.
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market is exhibiting steady growth amidst a dynamic business environment. The report is compiled to identify key growth avenues of the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market and challenges that pose threat to its expansion goals. It also…
